KR20030016227A - 약학적 조성물 - Google Patents

약학적 조성물 Download PDF

Info

Publication number
KR20030016227A
KR20030016227A KR1020027010571A KR20027010571A KR20030016227A KR 20030016227 A KR20030016227 A KR 20030016227A KR 1020027010571 A KR1020027010571 A KR 1020027010571A KR 20027010571 A KR20027010571 A KR 20027010571A KR 20030016227 A KR20030016227 A KR 20030016227A
Authority
KR
South Korea
Prior art keywords
composition
membrane
nail
enhancer
pharmaceutical compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020027010571A
Other languages
English (en)
Korean (ko)
Inventor
로버트 제이. 규릭
Original Assignee
벤트레이 파마슈티칼스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 벤트레이 파마슈티칼스, 인코포레이티드 filed Critical 벤트레이 파마슈티칼스, 인코포레이티드
Publication of KR20030016227A publication Critical patent/KR20030016227A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020027010571A 2000-02-16 2001-02-16 약학적 조성물 Ceased KR20030016227A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
US60/182,924 2000-02-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020087011722A Division KR20080049148A (ko) 2000-02-16 2001-02-16 약학적 조성물

Publications (1)

Publication Number Publication Date
KR20030016227A true KR20030016227A (ko) 2003-02-26

Family

ID=22670647

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020087011722A Withdrawn KR20080049148A (ko) 2000-02-16 2001-02-16 약학적 조성물
KR1020027010571A Ceased KR20030016227A (ko) 2000-02-16 2001-02-16 약학적 조성물

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020087011722A Withdrawn KR20080049148A (ko) 2000-02-16 2001-02-16 약학적 조성물

Country Status (17)

Country Link
EP (1) EP1257248B1 (enExample)
JP (1) JP2005503318A (enExample)
KR (2) KR20080049148A (enExample)
CN (1) CN1422142A (enExample)
AT (1) ATE526917T1 (enExample)
AU (2) AU4318901A (enExample)
BR (1) BR0108438A (enExample)
CA (1) CA2400178A1 (enExample)
HU (1) HUP0204555A3 (enExample)
MA (1) MA26883A1 (enExample)
MX (1) MXPA02008072A (enExample)
NO (1) NO20023866L (enExample)
NZ (1) NZ520749A (enExample)
PL (1) PL357111A1 (enExample)
TW (1) TWI232756B (enExample)
WO (1) WO2001060325A1 (enExample)
ZA (1) ZA200206553B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
CA2492976C (en) 2002-09-05 2011-11-01 Galderma Research & Development, S.N.C. Solution for ungual and peri-ungual application
HRP20050918A2 (en) * 2003-03-21 2006-12-31 Nexmed Holdings Antifungal nail coat and method of use
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
JP2009519940A (ja) * 2005-12-14 2009-05-21 ザーズ， インコーポレイテッド 皮膚科学的状態を処置するための組成物および方法
CN101351227A (zh) * 2005-12-28 2009-01-21 帝国制药株式会社 指甲用医药组合物
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
CA2752557A1 (en) * 2009-02-13 2010-08-19 Topica Pharmaceuticals, Inc. Anti-fungal formulation
CA2756047C (en) * 2009-03-20 2016-04-26 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
DE69216446T2 (de) * 1991-03-13 1997-06-26 Firmenich & Cie Verfahren zur Herstellung von 15-Pentadecanolid oder von an diesem Makrolid reichen Gemischen
WO1996012467A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
EP0983037B1 (en) * 1998-02-09 2003-05-02 MacroChem Corporation Antifungal nail lacquer
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
HUP0204555A3 (en) 2004-06-28
NO20023866L (no) 2002-10-01
BR0108438A (pt) 2003-04-01
HUP0204555A2 (en) 2003-05-28
AU4318901A (en) 2001-08-27
NO20023866D0 (no) 2002-08-15
ATE526917T1 (de) 2011-10-15
AU2001243189B2 (en) 2005-06-09
EP1257248B1 (en) 2011-10-05
EP1257248A4 (en) 2007-10-03
TWI232756B (en) 2005-05-21
NZ520749A (en) 2004-06-25
JP2005503318A (ja) 2005-02-03
KR20080049148A (ko) 2008-06-03
WO2001060325A1 (en) 2001-08-23
CA2400178A1 (en) 2001-08-23
PL357111A1 (en) 2004-07-12
EP1257248A1 (en) 2002-11-20
ZA200206553B (en) 2003-11-17
CN1422142A (zh) 2003-06-04
MXPA02008072A (es) 2004-04-05
MA26883A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
KR20030016227A (ko) 약학적 조성물
US20030049307A1 (en) Pharmaceutical composition
AU2001243189A1 (en) Pharmaceutical composition
US8741332B2 (en) Compositions and methods for dermally treating neuropathic pain
JP2635104B2 (ja) 抗真菌作用のあるネイルラツカー
JP3559973B2 (ja) 爪糸状菌症処置用皮フ病学的組成物中への親水性浸透剤の使用及び相当する組成物
US5346692A (en) Nail lacquer for the treatment of onychomycosis
CA2775393C (en) Topical non-aqueous pharmaceutical formulations
FI109333B (fi) Menetelmä topikaalisen valmisteen valmistamiseksi
CA1206418A (en) Antiinflammatory composition for external use
US20100267678A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
JPH01501143A (ja) 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
US20070196325A1 (en) Compositions and methods for dermally treating infections
US20070189978A1 (en) Compositions and methods for dermally treating musculoskeletal pain
KR101582448B1 (ko) 진균 감염 치료를 위한 신규 약학적 조성물
EP1959930A2 (en) Flux-enabling compositions and methods for dermal delivery of drugs
JPH10152433A (ja) 被膜形成性抗真菌剤組成物
JP2013501780A (ja) 爪の真菌感染を治療するための組成物及び方法
KR101333892B1 (ko) 항진균 조성물
CA2747845C (en) Compositions and methods for dermally treating pain
ES2295820T3 (es) Formulaciones de esmalte para las uñas eficaces antimicoticamente con 2-aminotiazoles sustituidos como sustancia activa.
HK1054874A (en) Pharmaceutical composition
US20180104227A1 (en) Nail lacquer composition containing ciclopirox

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020814

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20060206

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070226

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20080117

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20070226

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20080417

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20080117

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20080919

Appeal identifier: 2008101003461

Request date: 20080417

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20080516

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20080516

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20080417

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20071026

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080417

Effective date: 20080919

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20080919

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20080417

Decision date: 20080919

Appeal identifier: 2008101003461

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

PJ2001 Appeal

Patent event date: 20080919

Comment text: Trial Decision on Objection to Decision on Refusal

Patent event code: PJ20011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20081208

Appeal identifier: 2008201012814

Request date: 20081121

J122 Written withdrawal of action (patent court)
PJ1202 Withdrawal of action (patent court)

Patent event code: PJ12021R01D

Patent event date: 20081209

Comment text: Written Withdrawal of Action

Decision date: 20081208

Request date: 20081121

Appeal identifier: 2008201012814

Appeal kind category: Appeal against decision to decline refusal